Article PDF
References
Sadelain MWJ, Qin H, Lanzon J, Singh B (1990) Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39: 583–599
Havada M, Kishimoto Y, Makino S (1990) Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 8: 85–89
Shehadeh N, Calcinaro F, Bradley BJ, Brunchlim J, Vardi P, Lafferty KJ (1994) Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343: 706–707
Dahlquist G, Blom L, Tuvemo T, Nyström L, Sandström A, Wall S (1989) The Swedish childhood diabetes study - results from a nine-year case register and a one year case-referent study indicating that IDDM is associated with both NIDDM and autoimmune disorders. Diabetologia 32: 2–6
Ericson A, Gunnarskog J, Gustavsson D, Källén B, Malker B (1983) BCG vaccination and child cancer in Sweden. In: Crispen RG (ed) Cancer. Elsevier, Amsterdam, pp 411–417
Romanov V, Svensson Å, Hallander HO. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989. Tubercle and Lung Disease 1992; 73: 150–61
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dahlquist, G., Gothefors, L. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia 38, 873–874 (1995). https://doi.org/10.1007/BF03035306
Issue Date:
DOI: https://doi.org/10.1007/BF03035306